Overweight & Obesity

WHO, Lilly issue warnings about fake weight-loss drugs

Both the World Health Organization and Eli Lilly Co. warned Thursday that consumers should avoid fake versions of weight-loss drugs that are circulating in numerous countries.

Oncology & Cancer

FDA approves augtyro for NTRK-positive advanced solid tumors

The U.S. Food and Drug Administration has approved Augtyro (repotrectinib), a next-generation tyrosine kinase inhibitor (TKI), for the treatment of patients with neurotrophic tyrosine receptor kinase (NTRK)-positive locally ...

page 10 from 40